- C
Certest Biotec, S.L.
- Eduardo Laga Lázaro
Eduardo Laga Lázaro is a scientific communicator currently working at Factoría | HENNEO as a divulgador científico for the program Esta es mi Tierra on Aragón Televisión since October 2022. Simultaneously, Eduardo operates as a researcher under the Torres Quevedo program at CerTest Biotec, S.L. since July 2020. Previous experience includes presenting and writing for the scientific section of Eureka! on Aragón Televisión, and conducting research at various esteemed institutions such as the Consejo Superior de Investigaciones Científicas, Universidad de Zaragoza, and Instituto Catalán de Investigación Química. Eduardo holds a Master's in Secondary Education (Physics and Chemistry), a Doctorate in Inorganic Chemistry, and additional master's credentials in Chemical Research, all from Universidad de Zaragoza, where foundational studies in Physical Chemistry were also completed.
Org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Certest Biotec, S.L.
Highly specialized and customer-oriented, Certest Biotec consists of four divisions, including Raw Materials, Immunodiagnostics (Rapid Tests, Turbidimetry, and CLIA), Molecular Biology under the VIASURE brand, and Pharma. Certest Raw Materials provides high quality solutions for developing and manufacturing your IVD assays. Our expertise in protein expresión & purification, monoclonal antibodies develoment & manufacturing and primers & probes manufacturing offer to our customers a priceless support in their challenging proyects. Certest Immunodiagnostic -Rapid Test, Turbidimetry, CLIA- is committed to providing a comprehensive portfolio of diagnostic reagents for detecting infectious diseases and different markers, covering different needs of formats, types of use, throughput, precision and time from sample to result. VIASURE offers a reliable molecular diagnostic solution, from sample to intepretation of results, covering a wide range portfolio of products and enabling laboratories to better inform clinical decissions. The objective of Certest Pharma is to contribute with its technology to obtain better therapeutic products based on RNA. It is focused on three main áreas: RNAs, Delivery and Vaccines. Additionally, the expertise of our highly qualified personnel, currently numbering over 300 employees, is at the disposal of our customers, offering development and manufacturing services for the production of their own materials.
